Cervical cancer is one of the most preventable cancers, yet still remains the world’s third leading cancer killer in woman. All women are at risk for cervical cancer, and there is a higher occurrence in women over age thirty. Prevalence is much higher in countries with poor healthcare and poor economics in comparison to the United States. Research has been done and shows there is a genetic link for cervical cancer. Genetic testing can be beneficial at further assessing a women’s risk for cervical cancer. Cancer of the cervix can impact the cervix alone, but can also become more invasive and affect other gynecological organs. There are many treatments currently available as well as preventions such as vaccines on the market that are targeted at prevention of certain strains of HPV, which is almost always the cause of cervical cancer.
Cervical Cancer affects females only and is diagnosed between age twenty to age eighty-four. Very few cases are diagnosed are before age twenty and after age eighty-five. As previously stated all women are at risk for cervical cancer and occurs most in women over age thirty. Cervical cancer is usually slow growing and does not always have symptoms, but can be detected with routine examinations and Pap tests. Pap tests or Papanicolaou tests are a screening test that samples cervical cells to check for abnormalities. Prevalence is less in the United States due to routine Pap tests, whereas countries with poor healthcare and poor economics that do not preform pap tests as regularly have a higher incidence of cervical pre cancer and cancer. Besides Pap tests, genetic testing may be beneficial as well for risk assessment at the genetic level.
Research has been done in Britain and Canada and implies a major risk factor for cervical cancer involving the gene p53Arg. The gene p53 normally helps defend against tumors but has a variant form known as p53Arg. p53Arg is more easily prevented from working due to the affects...
Please join StudyMode to read the full document